VN

Vinit Nijhawan

Managing Director at MassVentures

Cambridge, Massachusetts

Overview 

Vinit Nijhawan is an accomplished investor, entrepreneur, and academic based in Cambridge, Massachusetts. Currently serving as the Managing Director at MassVentures and Interim Executive Director at MTTC, he has made significant contributions to the startup ecosystem through strategic partnerships and investments in companies such as Cala Systems, Worcester Polytechnic Institute, and Harvard University. Nijhawan's career highlights include his role as a Board Member at EnVision Endoscopy, Inc. and his work as an MBA Lecturer and Managing Director at Boston University's Office of Technology Development, where he has demonstrated expertise in technology transfer, venture capital, and new business development.

Work Experience 

  • Managing Director

    2020 - Current

    MTTC merged into MassVentures. MassVentures, a quasi-public entity was founded in 1978 and is focused on Deep Tech non-dilutive and dilutive funding with an added focus on diverse founders.

  • Interim Executive Director MTTC

    2018 - 2020

    MTTC enables Massachusetts public and private research universities and medical centers to lead the nation in translating basic research to the market, creating jobs and economic development to benefit Americans. Merged with MassVentures.

MassVentures is a venture capital firm focused on supporting Massachusetts-based startups to prosper in their businesses.

Raised $1,000,000.00 from US Department of Commerce, Economic Development Administation.

  • Board Member

    2023

    Suturing tools for endoscopes

EnVision Endoscopy is a medical device that provides endoscopic surgeries with solutions.

Raised $3,368,452.00 from MassVentures, MassVentures, MassVentures, National Science Foundation, National Science Foundation, MassChallenge, Massachusetts Life Sciences Center and National Science Foundation.

  • MBA Lecturer

    2008

    As a Lecturer teach MBA, Engineering and Medicine courses on entrepreneurship, and member of the Faculty Innovation Network of the BuildLab. Have taught entrepreneurship to over 600 students.

  • Managing Director Office of Technology Development

    2010 - 2016

    Launched eight venture-backed spinoffs (who have cumulatively raised over $350M) and generated more licensing royalty income than 34 years cumulative prior. Member of Coulter Oversight Committee at Biomedical Engineering. Member of BU CTSI Internal Advisory Board. Member of the Fraunhofer Alliance. Past member of the Conflict of Interest Committees for BU and BU School of Medicine.

  • Investor and Board Observer

    2023

  • Investor and Board Advisor

    2022

InGel Therapeutics is a platform technology company that develops stem cell therapeutics and biodegradable polymers.

  • Investor and Board Observer

    2022

  • Investor and Board Observer

    2022

Adden Energy is a developer of stable, lithium-metal, solid-state batteries.

Raised $20,149,974.00 from At One Ventures, MassVentures, Primavera Capital Group and Rhapsody Venture Partners.

  • Investor and Board Observer

    2022

  • Investor and Board Observer

    2021

Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.

Raised $39,098,461.00 from National Institute of Allergy and Infectious Diseases.

  • Investor and Board Observer

    2020

Concerto Biosciences reinvents humanity's relationship with microbes.

Raised $26,006,949.00 from Springboard Enterprises.

Education 

Articles About Vinit

Relevant Websites